Compare Novavax Inc (NVAX) vs VanEck Rare Earth/Strategic Metals (REMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs VanEck Rare Earth/Strategic Metals — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while VanEck Rare Earth/Strategic Metals trades at $71.57. Which is the better fit depends on your goals.
| NVAX | REMX | |
|---|---|---|
Market Cap | $1.30B | — |
Sector | Health | Sector/Thematic |
52-Week High | $11.19 | $109.53 |
52-Week Low | $6.22 | $49.22 |
Enterprise Value | $800.50M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About VanEck Rare Earth/Strategic Metals
REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.
Read more on REMX →
